ArticleAntibiotics (Basel, Switzerland)2020
Cytotoxicity and Antimycobacterial Properties of Pyrrolo[1,2-
Open access · goldAbstract read
In one paragraph
Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 46 citations in OpenAlex.
- Anticancer and Cyclooxygenase Inhibitory Activity of Benzylidene Derivatives of Fenobam and its Thio Analogues.Current medicinal chemistry · 2026Article
- Synthesis of Novel Arylhydrazones Bearing 8-Trifluoromethyl Quinoline: Crystal Insights, Larvicidal Activity, ADMET Predictions, and Molecular Docking Studies.Pharmaceuticals (Basel, Switzerland) · 2025Article
- Bio-computational modeling, POM analysis and molecular dynamic simulation for novel synthetic quinolone and benzo[d][1,3]oxazine candidates as antimicrobial inhibitors.Scientific reports · 2024Article
- Article
- Recent Advances in Pharmaceutical Design: Unleashing the Potential of Novel Therapeutics.Current pharmaceutical biotechnology · 2024Review
- Synthesis, Molecular Docking Study, and Biological Evaluation of New 4-(2,5-Dimethyl-1Antibiotics (Basel, Switzerland) · 2023Article
- Cytotoxic Activity of α-Aminophosphonic Derivatives Coming from the Tandem Kabachnik-Fields Reaction and Acylation.Pharmaceuticals (Basel, Switzerland) · 2023Article
- Development of Novel Isatin-Tethered Quinolines as Anti-Tubercular Agents against Multi and Extensively Drug-ResistantMolecules (Basel, Switzerland) · 2022Article
- Progress Report: Antimicrobial Drug Discovery in the Resistance Era.Pharmaceuticals (Basel, Switzerland) · 2022Review
- Article
- Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme.Journal of enzyme inhibition and medicinal chemistry · 2021Article
- Review
- Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives.Molecules (Basel, Switzerland) · 2021Article
- Investigation of Antifungal Properties of Synthetic Dimethyl-4-Bromo-1-(Substituted Benzoyl) Pyrrolo[1,2-a] Quinoline-2,3-Dicarboxylates Analogues: Molecular Docking Studies and Conceptual DFT-Based Chemical Reactivity Descriptors and Pharmacokinetics Evaluation.Molecules (Basel, Switzerland) · 2021Article
- Anti-Tubercular Properties of 4-Amino-5-(4-Fluoro-3- Phenoxyphenyl)-4Antibiotics (Basel, Switzerland) · 2020Article
- Crystallography, in Silico Studies, and In Vitro Antifungal Studies of 2,4,5 Trisubstituted 1,2,3-Triazole Analogues.Antibiotics (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 11 institutions in 6 countries.
Katharigatta N VenugopalaDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0003-0680-1549
Vijayakumar UpparDepartment of Chemistry, School of Basic Science, Rani Channamma University, Belagavi 591156, India.ORCID 0000-0003-2291-6477
Sandeep ChandrashekharappaInstitute for Stem Cell Biology and Regenerative Medicine, National Center for Biological Sciences (NCBS), Tata Institute of Fundamental Research (TIFR), Gandhi Krishi Vignana Kendra (GKVK) Campus, Bangalore 560065, India.ORCID 0000-0003-2475-7270
Hassan H AbdallahChemistry Department, College of Education, Salahaddin University, Erbil 44001, Iraq.ORCID 0000-0002-9198-0475
Melendhran PillayDepartment of Microbiology, National Health Laboratory Services, KZN Academic Complex, Inkosi Albert Luthuli Central Hospital, Durban 4001, South Africa.
Pran Kishore DebFaculty of Pharmacy, Philadelphia University, Amman 19392, Jordan.ORCID 0000-0002-8650-2874
Mohamed A MorsyDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0002-6752-9094
Bandar E AldhubiabDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0002-2684-4186
Mahesh AttimaradDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0002-7007-9119
Anroop B NairDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0003-2850-8669
Nagaraja SreeharshaDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0002-2058-255X
Christophe TratratDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0001-9064-1706
Abdulmuttaleb Yousef JaberFaculty of Pharmacy, Philadelphia University, Amman 19392, Jordan.ORCID 0000-0002-7769-0770
Rashmi VenugopalaDepartment of Public Health Medicine, University of KwaZulu-Natal, Howard College Campus, Durban 4001, South Africa.ORCID 0000-0002-1101-4577
Raghu Prasad MailavaramDepartment of Pharmaceutical Chemistry, Shri Vishnu College of Pharmacy, Vishnupur, Bhimavaram 534 202, India.ORCID 0000-0001-6126-5860
Bilal A Al-JaidiFaculty of Pharmacy, Yarmouk University, Irbid 21163, Jordan.ORCID 0000-0003-3308-8697
Mahmoud KandeelDepartment of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Michelyne HarounDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Basavaraj PadmashaliDepartment of Chemistry, School of Basic Science, Rani Channamma University, Belagavi 591156, India.
King Faisal University · SAPhiladelphia University · JORani Channamma University, Belagavi · INDurban University of Technology · ZAHindu College of Pharmacy · INKafrelsheikh University · EGNational Health Laboratory Service · ZASalahaddin University-Erbil · IQTata Institute of Fundamental Research · INUniversity of KwaZulu-Natal · ZAYarmouk University · JO
Funding
Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia Research Project Number 1058
Abstract
A series of ethyl 1-(substituted benzoyl)-5-methylpyrrolo[1,2-
Indexed as
computational studiescytotoxicityH37RvMDR-MTBminimum inhibitory concentrationmolecular target identificationMycobacterium tuberculosispyrrolo[1,2-a]quinoline
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.